Gene editing: beyond the hype

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities.

ASH: CRISPR, Vertex' CTX001 hits the mark in red cell disord...

A gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has achieved “remarkable” improvements in patients with beta thalassaemia and sickle cell disease in an early-stage tr

CRISPR pioneers Doudna and Charpentier claim Nobel chemistry...

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9.

Stem cell transplant eradicates HIV in second patient

First patient dosed in trial of Allergan/Editas’ CRISPR blin...

4th Annual Genome Editing USA Congress

2 days, 350+ end users, 80+ case studies